Trials / Unknown
UnknownNCT02934204
Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 51 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Consolidation treatment for Primary Central Nervous System Diffuse Large B cell Lymphoma(PCNSL)patients remains to be defined.Here we designed a tolerated treatment of HDMTX plus Temozolomide,followed by consolidation with Temozolomide in PCNSL patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | methotrexate | |
| DRUG | temozolomide |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2016-10-14
- Last updated
- 2016-10-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02934204. Inclusion in this directory is not an endorsement.